Livestock Vaccines Market – Scope of Report TMR’s report on the global livestock vaccines market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global livestock vaccines market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global livestock vaccines market from 2023 to 2031. The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the livestock vaccines market. Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global livestock vaccines market. The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global livestock vaccines market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global livestock vaccines market. The report delves into the competitive landscape of the global livestock vaccines market. Key players operating in the global livestock vaccines market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global livestock vaccines market profiled in this report. Key Questions Answered in Global livestock vaccines Market Report • What is the sales/revenue generated by livestock vaccines across all regions during the forecast period? • What are the opportunities in the global livestock vaccines market? • What are the major drivers, restraints, opportunities, and threats in the market? • Which regional market is set to expand at the fastest CAGR during the forecast period? • Which segment is expected to generate the highest revenue globally in 2031? • Which segment is projected to expand at the highest CAGR during the forecast period? • What are the market positions of different companies operating in the global market? Livestock Vaccines Market – Research Objectives and Research Approach The comprehensive report on the global livestock vaccines market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period. The report analyzes the global livestock vaccines market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global livestock vaccines market.

1 Preface 1.1 Market Definition and Scope 1.2 Market Segmentation 1.3 Key Research Objectives 1.4 Research Highlights 2 Assumptions and Research Methodology 3 Executive Summary: Global Livestock Vaccines Market 4 Market Overview 4.1 Introduction 4.1.1 Segment Definition 4.2 Overview 4.3 Market Dynamics 4.3.1 Drivers 4.3.2 Restraints 4.3.3 Opportunities 4.4 Global Livestock Vaccines Market Analysis and Forecast, 2023-2031 5 Key Insights 5.1 Disease Epidemiology 5.2 Pipeline Analysis 5.3 Key Industry Events 5.4 COVID-19 Pandemic Impact on Industry 6 Global Livestock Vaccines Market Analysis and Forecast, by Vaccine Type 6.1 Introduction & Definition 6.2 Key Findings/Developments 6.3 Market Value Forecast, by Vaccine Type, 2023-2031 6.3.1 Bovine Vaccine 6.3.2 Poultry Vaccine 6.3.3 Porcine Vaccine 6.3.4 Others 6.4 Market Attractiveness Analysis, by Vaccine Type 7 Global Livestock Vaccines Market Analysis and Forecast, by Technology 7.1 Introduction & Definition 7.2 Key Findings/Developments 7.3 Market Value Forecast, by Technology, 2023-2031 7.3.1 Live Attenuated Vaccine 7.3.2 Inactivated Vaccine 7.3.3 Recombinant Vaccine 7.3.4 Others 7.4 Market Attractiveness Analysis, by Technology 8 Global Livestock Vaccines Market Analysis and Forecasts, by Route of Administration 8.1 Introduction & Definition 8.2 Key Findings/Developments 8.3 Market Value Forecast, by Route of Administration, 2023-2031 8.3.1 Oral 8.3.2 Parenteral 8.3.3 Others 8.4 Market Attractiveness Analysis, by Route of Administration 9 Global Livestock Vaccines Market Analysis and Forecast, by End-user 9.1 Introduction & Definition 9.2 Key Findings/Developments 9.3 Market Value Forecast, by End-user, 2023-2031 9.3.1 Veterinary Hospitals 9.3.2 Veterinary Clinics 9.3.3 Others 9.4 Market Attractiveness Analysis, by End-user 10 Global Livestock Vaccines Market Analysis and Forecast, by Region 10.1 Key Findings 10.2 Market Value Forecast, by Region, 2023-2031 10.2.1 North America 10.2.2 Europe 10.2.3 Asia Pacific 10.2.4 Latin America 10.2.5 Middle East & Africa 10.3 Market Attractiveness By Country/Region 11 North America Livestock Vaccines Market Analysis and Forecast 11.1 Introduction 11.1.1 Key Findings 11.2 Market Value Forecast, by Vaccine Type, 2023-2031 11.2.1 Bovine Vaccine 11.2.2 Poultry Vaccine 11.2.3 Poultry Vaccine 11.2.4 Others 11.3 Market Value Forecast, by Technology, 2023-2031 11.3.1 Live Attenuated Vaccine 11.3.2 Inactivated Vaccine 11.3.3 Recombinant Vaccine 11.3.4 Others 11.4 Market Value Forecast, by Route of Administration, 2023-2031 11.4.1 Oral 11.4.2 Parenteral 11.4.3 Others 11.5 Market Value Forecast, by End-user, 2023-2031 11.5.1 Veterinary Hospitals 11.5.2 Veterinary Clinics 11.5.3 Others 11.6 Market Value Forecast, by Country, 2023-2031 11.6.1 U.S 11.6.2 Canada 11.7 Market Attractiveness Analysis 11.7.1 By Vaccine Type 11.7.2 By Technology 11.7.3 By Route of Administration 11.7.4 By End-user 11.7.5 By Country/Sub-region 12 Europe Livestock Vaccines Market Analysis and Forecast 12.1 Introduction 12.1.1 Key Findings 12.2 Market Value Forecast, by Vaccine Type, 2023-2031 12.2.1 Bovine Vaccine 12.2.2 Poultry Vaccine 12.2.3 Porcine Vaccine 12.2.4 Others 12.3 Market Value Forecast, by Technology, 2023-2031 12.3.1 Live Attenuated Vaccine 12.3.2 Inactivated Vaccine 12.3.3 Recombinant Vaccine 12.3.4 Others 12.4 Market Value Forecast, by Route of Administration, 2023-2031 12.4.1 Oral 12.4.2 Parenteral 12.4.3 Others 12.5 Market Value Forecast, by End-user, 2023-2031 12.5.1 Veterinary Hospitals 12.5.2 Veterinary Clinics 12.5.3 Others 12.6 Market Value Forecast, by Country/Sub-region, 2023-2031 12.6.1 Germany 12.6.2 U.K 12.6.3 France 12.6.4 Italy 12.6.5 Spain 12.6.6 Rest of Europe 12.7 Market Attractiveness Analysis 12.7.1 By Vaccine Type 12.7.2 By Technology 12.7.3 By Route of Administration 12.7.4 By End-user 12.7.5 By Country/Sub-region 13 Asia Pacific Livestock Vaccines Market Analysis and Forecast 13.1 Introduction 13.1.1 Key Findings 13.2 Market Value Forecast, by Vaccine Type, 2023-2031 13.2.1 Bovine Vaccine 13.2.2 Poultry Vaccine 13.2.3 Porcine Vaccine 13.2.4 others 13.3 Market Value Forecast, by Technology, 2023-2031 13.3.1 Live Attenuated Vaccine 13.3.2 Inactivated Vaccine 13.3.3 Recombinant Vaccine 13.3.4 Others 13.4 Market Value Forecast, by Route of Administration, 2023-2031 13.4.1 Oral 13.4.2 Parenteral 13.4.3 Others 13.5 Market Value Forecast, by End-user, 2023-2031 13.5.1 Veterinary Hospitals 13.5.2 Veterinary Clinics 13.5.3 Others 13.6 Market Value Forecast, by Country/Sub-region, 2023-2031 13.6.1 China 13.6.2 Japan 13.6.3 India 13.6.4 Australia & New Zealand 13.6.5 Rest of Asia Pacific 13.7 Market Attractiveness Analysis 13.7.1 By Vaccine Type 13.7.2 By Technology 13.7.3 By Route of Administration 13.7.4 By End-user 13.7.5 By Country/Sub-region 14 Latin America Livestock Vaccines Market Analysis and Forecast 14.1 Introduction 14.1.1 Key Findings 14.2 Market Value Forecast, by Vaccine Type, 2023-2031 14.2.1 Bovine Vaccine 14.2.2 Poultry Vaccine 14.2.3 Porcine Vaccine 14.2.4 Others Vaccine 14.3 Market Value Forecast, by Technology, 2023-2031 14.3.1 Live Attenuated Vaccine 14.3.2 Inactivated Vaccine 14.3.3 Recombinant Vaccine 14.3.4 Others 14.4 Market Value Forecast, by Route of Administration, 2023-2031 14.4.1 Oral 14.4.2 Parenteral 14.4.3 Others 14.5 Market Value Forecast, by End-user, 2023-2031 14.5.1 Veterinary Hospitals 14.5.2 Veterinary Clinics 14.5.3 Others 14.6 Market Value Forecast, by Country/Sub-region, 2023-2031 14.6.1 Brazil 14.6.2 Mexico 14.6.3 Rest of Latin America 14.7 Market Attractiveness Analysis 14.7.1 By Vaccine Type 14.7.2 By Technology 14.7.3 By Route of Administration 14.7.4 By End-user 14.7.5 By Country/Sub-region 15 Middle East & Africa Livestock Vaccines Market Analysis and Forecast 15.1 Introduction 15.1.1 Key Findings 15.2 Market Value Forecast, by Vaccine Type, 2023-2031 15.2.1 Bovine Vaccine 15.2.2 Poultry Vaccine 15.2.3 Porcine Vaccine 15.2.4 Others 15.3 Market Value Forecast, by Technology, 2023-2031 15.3.1 Live Attenuated Vaccine 15.3.2 Inactivated Vaccine 15.3.3 Recombinant Vaccine 15.3.4 Others 15.4 Market Value Forecast, by Route of Administration, 2023-2031 15.4.1 Oral 15.4.2 Parenteral 15.4.3 Others 15.5 Market Value Forecast, by End-user, 2023-2031 15.5.1 Veterinary Hospitals 15.5.2 Veterinary Clinics 15.5.3 Others 15.6 Market Value Forecast, by Country/Sub-region, 2023-2031 15.6.1 GCC Countries 15.6.2 South Africa 15.6.3 Rest of Middle East & Africa 15.7 Market Attractiveness Analysis 15.7.1 By Vaccine Type 15.7.2 By Technology 15.7.3 By Route of Administration 15.7.4 By End-user 15.7.5 By Country/Sub-region 16 Competition Landscape 16.1 Market Player - Competition Matrix (By Tier and Size of Companies) 16.2 Market Share Analysis, by Company (2022) 16.3 Company Profiles 16.3.1 Dechra Pharmaceuticals PLC 16.3.1.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.1.2 Product Portfolio 16.3.1.3 Financial Overview 16.3.1.4 SWOT Analysis 16.3.1.5 Strategic Overview 16.3.2 Ceva Santé Animale 16.3.2.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.2.2 Product Portfolio 16.3.2.3 Financial Overview 16.3.2.4 SWOT Analysis 16.3.2.5 Strategic Overview 16.3.3 Elanco 16.3.3.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.3.2 Product Portfolio 16.3.3.3 Financial Overview 16.3.3.4 SWOT Analysis 16.3.3.5 Strategic Overview 16.3.4 Merck & Co., Inc 16.3.4.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.4.2 Product Portfolio 16.3.4.3 Financial Overview 16.3.4.4 SWOT Analysis 16.3.4.5 Strategic Overview 16.3.5 Zoetis Services LLC 16.3.5.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.5.2 Product Portfolio 16.3.5.3 Financial Overview 16.3.5.4 SWOT Analysis 16.3.5.5 Strategic Overview 16.3.6 Boehringer Ingelheim International GmbH 16.3.6.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.6.2 Product Portfolio 16.3.6.3 Financial Overview 16.3.6.4 SWOT Analysis 16.3.6.5 Strategic Overview 16.3.7 Virbac 16.3.7.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.7.2 Product Portfolio 16.3.7.3 Financial Overview 16.3.7.4 SWOT Analysis 16.3.7.5 Strategic Overview 16.3.8 Biogénesis Bagó 16.3.8.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.8.2 Product Portfolio 16.3.8.3 Financial Overview 16.3.8.4 SWOT Analysis 16.3.8.5 Strategic Overview 16.3.9 Ourofino Saúde Animal 16.3.9.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.9.2 Product Portfolio 16.3.9.3 Financial Overview 16.3.9.4 SWOT Analysis 16.3.9.5 Strategic Overview 16.3.10 VETAL Animal Health Products, Inc 16.3.10.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.10.2 Product Portfolio 16.3.10.3 Financial Overview 16.3.10.4 SWOT Analysis 16.3.10.5 Strategic Overview 16.3.11 Other prominent Players 16.3.11.1 Company Overview (HQ, Business Segments, Employee Strength) 16.3.11.2 Product Portfolio 16.3.11.3 Financial Overview 16.3.11.4 SWOT Analysis 16.3.11.5 Strategic Overview